Heat-Health Early Warning Systems
Europe · 1 shared keyword
Updated
Reviewed by Vidhi Upadhyay
Europe Disease Surveillance Systems Market Industry Trends and Forecast to 2034: Segmented by (Type, User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.25 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.37 Bn | — | — |
| 2025 (base) | $1.47 Bn | +$97.4 Mn | — |
| 2026 (forecast) | $1.57 Bn | +$104.3 Mn | +7.1% |
| 2027 (forecast) | $1.68 Bn | +$111.7 Mn | +14.7% |
| 2028 (forecast) | $1.80 Bn | +$119.6 Mn | +22.8% |
| 2029 (forecast) | $1.93 Bn | +$128.1 Mn | +31.6% |
| 2030 (forecast) | $2.07 Bn | +$137.2 Mn | +40.9% |
| 2031 (forecast) | $2.22 Bn | +$146.9 Mn | +50.9% |
| 2032 (forecast) | $2.37 Bn | +$157.4 Mn | +61.6% |
| 2033 (forecast) | $2.54 Bn | +$168.5 Mn | +73.1% |
| 2034 (forecast) | $2.72 Bn | +$180.5 Mn | +85.4% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.47 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $2.72 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Type and user (see all) |
| Key players | SAS Institute, Biobot Analytics, Ginkgo Bioworks, BlueDot, Esri (see all) |
| Regulator in Europe | EU MDRSource: European Commission, medical devices. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Disease surveillance systems collect and analyse data to spot outbreaks early and guide public health action.
Key segments of the disease Surveillance Systems market include type (Syndromic Surveillance, Lab-Based Surveillance and Genomic Surveillance) and user (Governments, WHO and NGOs and Hospitals).
Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the disease Surveillance Systems market.
Digital tools for community health, local manufacturing and public-private partnerships give the disease Surveillance Systems market room to grow.
Limited budgets, weak health systems in some regions, workforce shortages and supply chain gaps hold back the disease Surveillance Systems market.
The disease Surveillance Systems market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device.[1] In some of the countries we cover here, rules for health software come from EU MDR and ANSM (France)[1], BfArM (DiGA) (Germany)[2], EU MDR and Ministry of Health (Italy)[1], EU MDR and AEMPS (Spain)[1] and MHRA (UK)[3]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.[4]
[1] European Commission, medical devices. Checked 14 Nov 2026.
[2] BfArM DiGA directory. Checked 14 Nov 2026.
[3] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
[4] European Commission, health technology assessment. Checked 14 Nov 2026.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the disease Surveillance Systems market. Government digital health programs in Europe are speeding up adoption.
What doctors and scientists are doing in Disease Surveillance Systems right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Europe · 1 shared keyword
Europe · 1 shared keyword
Europe · 1 shared keyword
Europe · 1 shared keyword
Europe · 1 shared keyword
Europe
Medical Devices · Europe
Medical Devices · Europe
Pharmaceuticals · Europe
OTC & Nutraceuticals · Europe
Pharmaceuticals · Europe
Medical Devices · Europe